As of May 2024 UroGen Pharma has a market cap of $0.51 Billion. This makes UroGen Pharma the world's 5972th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.51 B | 11.59% |
2023 | $0.46 B | 126.06% |
2022 | $0.20 B | -4.13% |
2021 | $0.21 B | -46.52% |
2020 | $0.39 B | -43.07% |
2019 | $0.70 B | 0.49% |
2018 | $0.69 B | 42.39% |
2017 | $0.49 B |
On May 3rd, 2024 the market cap of UroGen Pharma was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.65 B | 26.71% | ๐บ๐ธ USA |